195 related articles for article (PubMed ID: 29419481)
1. Noninvasive Whole-Body Imaging of Phosphatidylethanolamine as a Cell Death Marker Using
Delvaeye T; Wyffels L; Deleye S; Lemeire K; Gonçalves A; Decrock E; Staelens S; Leybaert L; Vandenabeele P; Krysko DV
J Nucl Med; 2018 Jul; 59(7):1140-1145. PubMed ID: 29419481
[TBL] [Abstract][Full Text] [Related]
2. Early Prediction of Tumor Response to Treatment: Preclinical Validation of 99mTc-Duramycin.
Elvas F; Vangestel C; Pak K; Vermeulen P; Gray B; Stroobants S; Staelens S; Wyffels L
J Nucl Med; 2016 May; 57(5):805-11. PubMed ID: 26837335
[TBL] [Abstract][Full Text] [Related]
3. Understanding the in vivo uptake kinetics of a phosphatidylethanolamine-binding agent (99m)Tc-Duramycin.
Audi S; Li Z; Capacete J; Liu Y; Fang W; Shu LG; Zhao M
Nucl Med Biol; 2012 Aug; 39(6):821-5. PubMed ID: 22534031
[TBL] [Abstract][Full Text] [Related]
4.
Elvas F; Boddaert J; Vangestel C; Pak K; Gray B; Kumar-Singh S; Staelens S; Stroobants S; Wyffels L
J Nucl Med; 2017 Apr; 58(4):665-670. PubMed ID: 27879368
[TBL] [Abstract][Full Text] [Related]
5. The feasibility of imaging myocardial ischemic/reperfusion injury using (99m)Tc-labeled duramycin in a porcine model.
Wang L; Wang F; Fang W; Johnson SE; Audi S; Zimmer M; Holly TA; Lee DC; Zhu B; Zhu H; Zhao M
Nucl Med Biol; 2015 Feb; 42(2):198-204. PubMed ID: 25451214
[TBL] [Abstract][Full Text] [Related]
6. [
Li Y; Liu C; Xu X; Lu X; Luo J; Gray B; Pak KY; Cheng J; Zhang Y
Nucl Med Biol; 2018 Nov; 66():18-25. PubMed ID: 30170197
[TBL] [Abstract][Full Text] [Related]
7. Molecular Imaging of Apoptosis in Ischemia Reperfusion Injury With Radiolabeled Duramycin Targeting Phosphatidylethanolamine: Effective Target Uptake and Reduced Nontarget Organ Radiation Burden.
Kawai H; Chaudhry F; Shekhar A; Petrov A; Nakahara T; Tanimoto T; Kim D; Chen J; Lebeche D; Blankenberg FG; Pak KY; Kolodgie FD; Virmani R; Sengupta P; Narula N; Hajjar RJ; Strauss HW; Narula J
JACC Cardiovasc Imaging; 2018 Dec; 11(12):1823-1833. PubMed ID: 29454770
[TBL] [Abstract][Full Text] [Related]
8. Whole-body imaging of high-dose ionizing irradiation-induced tissue injuries using 99mTc-duramycin.
Johnson SE; Li Z; Liu Y; Moulder JE; Zhao M
J Nucl Med; 2013 Aug; 54(8):1397-403. PubMed ID: 23804327
[TBL] [Abstract][Full Text] [Related]
9. Early prediction of tumor response after radiotherapy in combination with cetuximab in nasopharyngeal carcinoma using
Liu C; Li Y; Qin X; Yang Z; Luo J; Zhang J; Gray B; Pak KY; Xu X; Cheng J; Zhang Y
Biomed Pharmacother; 2020 May; 125():109947. PubMed ID: 32058215
[TBL] [Abstract][Full Text] [Related]
10. A Comparison of [
Hu Y; Liu G; Zhang H; Li Y; Gray BD; Pak KY; Choi HS; Cheng D; Shi H
Mol Imaging Biol; 2018 Apr; 20(2):249-259. PubMed ID: 28785938
[TBL] [Abstract][Full Text] [Related]
11. [
Palmieri L; Elvas F; Vangestel C; Pak K; Gray B; Stroobants S; Staelens S; Wyffels L
Nucl Med Biol; 2018 Jan; 56():1-9. PubMed ID: 29031229
[TBL] [Abstract][Full Text] [Related]
12. Monitoring Apoptosis of Breast Cancer Xenograft After Paclitaxel Treatment With 99mTc-Labeled Duramycin SPECT/CT.
Luo R; Niu L; Qiu F; Fang W; Fu T; Zhao M; Zhang YJ; Hua ZC; Li XF; Wang F
Mol Imaging; 2016; 15():. PubMed ID: 27030401
[TBL] [Abstract][Full Text] [Related]
13. Characterization of [(99m)Tc]Duramycin as a SPECT Imaging Agent for Early Assessment of Tumor Apoptosis.
Elvas F; Vangestel C; Rapic S; Verhaeghe J; Gray B; Pak K; Stroobants S; Staelens S; Wyffels L
Mol Imaging Biol; 2015 Dec; 17(6):838-47. PubMed ID: 25896815
[TBL] [Abstract][Full Text] [Related]
14. First-in-human study of a novel cell death tracer [
Metelerkamp Cappenberg T; De Schepper S; Vangestel C; De Lombaerde S; Wyffels L; Van den Wyngaert T; Mattis J; Gray B; Pak K; Stroobants S; Elvas F
EJNMMI Radiopharm Chem; 2023 Aug; 8(1):20. PubMed ID: 37646865
[TBL] [Abstract][Full Text] [Related]
15. Detection of atherosclerotic plaques in ApoE-deficient mice using (99m)Tc-duramycin.
Liu Z; Larsen BT; Lerman LO; Gray BD; Barber C; Hedayat AF; Zhao M; Furenlid LR; Pak KY; Woolfenden JM
Nucl Med Biol; 2016 Aug; 43(8):496-505. PubMed ID: 27236285
[TBL] [Abstract][Full Text] [Related]
16. Differential lung uptake of 99mTc-hexamethylpropyleneamine oxime and 99mTc-duramycin in the chronic hyperoxia rat model.
Clough AV; Audi SH; Haworth ST; Roerig DL
J Nucl Med; 2012 Dec; 53(12):1984-91. PubMed ID: 23086010
[TBL] [Abstract][Full Text] [Related]
17. Imaging assessment of cardioprotection mediated by a dodecafluoropentane oxygen-carrier administered during myocardial infarction.
Liu Z; Barber C; Gupta A; Wan L; Won YW; Furenlid LR; Chen Q; Desai AA; Zhao M; Bull DA; Unger EC; Martin DR
Nucl Med Biol; 2019 Mar; 70():67-77. PubMed ID: 30772168
[TBL] [Abstract][Full Text] [Related]
18. A single-step kit formulation for the (99m)Tc-labeling of HYNIC-Duramycin.
Zhao M; Li Z
Nucl Med Biol; 2012 Oct; 39(7):1006-11. PubMed ID: 22858374
[TBL] [Abstract][Full Text] [Related]
19.
Tan H; Abudupataer M; Qiu L; Mao W; Xiao J; Cheng D; Shi H
Chem Biol Drug Des; 2021 Feb; 97(2):210-220. PubMed ID: 32881342
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT.
Gainkam LO; Huang L; Caveliers V; Keyaerts M; Hernot S; Vaneycken I; Vanhove C; Revets H; De Baetselier P; Lahoutte T
J Nucl Med; 2008 May; 49(5):788-95. PubMed ID: 18413403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
